YSQTG
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for YSQTG, covering 2025-03-07 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer [NA]